Zürich-based Immitra Bio secures €2.58 million to scale its scalable in-vivo genetic medicine platform
Zürich-based Immitra Bio secures €2.58 million to scale its scalable in-vivo genetic medicine platform — reported by eu-startups.com, aggregated and ranked by ClawDigest.